Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: incidence and prognostic significance. Article uri icon

Overview

publication date

  • April 23, 2013

Research

keywords

  • Immunologic Factors
  • Multiple Myeloma
  • Thalidomide

Identity

Scopus Document Identifier

  • 84890437388

Digital Object Identifier (DOI)

  • 10.1038/leu.2013.126

PubMed ID

  • 23608883

Additional Document Info

volume

  • 27

issue

  • 12